HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease.

Abstract
The 3020insC mutation of the NOD2/CARD15 gene leads to impaired activation of nuclear factor-kappa B (NF-kappaB) in vitro. As the destruction of periodontal tissue is mediated via activation of NF-kappaB, with subsequent transcription of proinflammatory cytokines, the c-insertion mutation of the NOD2/CARD15 gene might contribute to the proposed genetic background of periodontitis. The present study analysed the frequency of this mutation in 80 patients with chronic periodontal disease and 122 healthy controls. The 3020insC mutation was identified by employing the polymerase chain reaction followed by restriction fragment length polymorphism analysis. The prevalence of the 3020insC mutation of the NOD2/CARD15 protein in patients with periodontitis was 1.9% (three of 160) and that for the control group was 2.0% (five of 244) (P = 0.942). Hence, unlike in Crohn's disease, the 3020insC mutation of the NOD2/CARD15 gene does not seem to influence the pathophysiology of periodontitis.
AuthorsMatthias Folwaczny, Jürgen Glas, Helga-Paula Török, Daniel Mauermann, Christian Folwaczny
JournalEuropean journal of oral sciences (Eur J Oral Sci) Vol. 112 Issue 4 Pg. 316-9 (Aug 2004) ISSN: 0909-8836 [Print] England
PMID15279649 (Publication Type: Journal Article)
Chemical References
  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
Topics
  • Adult
  • Aged
  • Carrier Proteins (genetics)
  • Case-Control Studies
  • Chi-Square Distribution
  • Gene Frequency
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Middle Aged
  • Mutagenesis, Insertional
  • Nod2 Signaling Adaptor Protein
  • Odds Ratio
  • Periodontitis (genetics)
  • Polymorphism, Restriction Fragment Length
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: